))
Chikungunya Vaccine Trial: Exploring the Results
Manage episode 436702581 series 3517021
ReachMD द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री ReachMD या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Host: Matt Birnholz, MD
Chikungunya is a mosquito-transmitted viral disease that is highly likely to spread globally through patients who are traveling. So a phase three clinical trial aimed to test the safety and immunogenicity of the VLA1553 vaccine against this virus. Dive in to learn about the methods and results of this trial with Dr. Matt Birnholz, ReachMD host. Valneva did not contribute to the educational content.
…
continue reading
Chikungunya is a mosquito-transmitted viral disease that is highly likely to spread globally through patients who are traveling. So a phase three clinical trial aimed to test the safety and immunogenicity of the VLA1553 vaccine against this virus. Dive in to learn about the methods and results of this trial with Dr. Matt Birnholz, ReachMD host. Valneva did not contribute to the educational content.
40 एपिसोडस
साझा करें
